Shares of Stericycle, Inc. (NASDAQ:SRCL – Get Free Report) have been assigned an average recommendation of “Hold” from the six research firms that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $74.00.
A number of research analysts recently issued reports on the stock. Robert W. Baird decreased their price objective on shares of Stericycle from $62.00 to $55.00 and set a “neutral” rating for the company in a report on Friday, April 26th. StockNews.com initiated coverage on shares of Stericycle in a research report on Monday. They set a “hold” rating on the stock. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $62.00 price target (down from $69.00) on shares of Stericycle in a research report on Tuesday, June 4th. Truist Financial increased their price objective on shares of Stericycle from $50.00 to $62.00 and gave the company a “hold” rating in a research report on Tuesday, June 4th. Finally, Keefe, Bruyette & Woods upped their price target on shares of Stericycle from $135.00 to $142.00 and gave the company an “outperform” rating in a research note on Tuesday, June 4th.
Read Our Latest Stock Report on SRCL
Institutional Investors Weigh In On Stericycle
Stericycle Stock Down 0.1 %
Stericycle stock opened at $58.27 on Wednesday. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.55. The company has a market capitalization of $5.41 billion, a P/E ratio of -264.86, a P/E/G ratio of 3.14 and a beta of 1.11. The firm’s fifty day simple moving average is $54.05 and its 200-day simple moving average is $51.39. Stericycle has a 1-year low of $37.78 and a 1-year high of $59.45.
Stericycle (NASDAQ:SRCL – Get Free Report) last issued its earnings results on Thursday, April 25th. The business services provider reported $0.57 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.03. Stericycle had a negative net margin of 0.74% and a positive return on equity of 7.31%. The business had revenue of $664.90 million for the quarter, compared to analyst estimates of $676.42 million. During the same period in the previous year, the business earned $0.49 EPS. The firm’s revenue was down 2.8% on a year-over-year basis. Sell-side analysts forecast that Stericycle will post 2.32 earnings per share for the current fiscal year.
Stericycle Company Profile
Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.
Read More
- Five stocks we like better than Stericycle
- How to Use Stock Screeners to Find Stocks
- Top 3 Defense Stocks That Should Be on Your Radar
- How to Calculate Return on Investment (ROI)
- Why This Banking Stock Might Be Nearing the Bottom of Its Cycle
- What Does Downgrade Mean in Investing?
- MarketBeat Week in Review – 7/8 – 7/12
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.